Education
About Us
Working with TipRanks
Follow Us
Genomtec SA (DE:4VI)
:4VI
| Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | ||||
| Gross Profit | $ -5.16M | $ -3.51M | $ -122.07K | $ -119.83K |
| Operating Income | $ -6.98M | $ -10.86M | $ -1.61M | $ -1.25M |
| EBITDA | $ -6.58M | $ -10.67M | $ -1.51M | $ -1.20M |
| Net Income | $ -7.12M | $ -10.94M | $ -1.62M | $ -742.71K |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 4.22M | $ 9.37M | $ 2.20M | $ 473.47K |
| Total Debt | $ 1.75M | $ 1.03M | $ 599.97K | $ 0.00 |
| Net Debt | $ 363.00K | $ -6.27M | $ 599.97K | $ 0.00 |
| Total Liabilities | $ 3.49M | $ 1.80M | $ 1.25M | $ 41.09K |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | ||||
| Free Cash Flow | $ -5.71M | $ -2.63M | $ -3.21M | - |
| Operating Cash Flow | $ -5.50M | $ -2.50M | - | - |
| Investing Cash Flow | ||||
| Financing Cash Flow |
Genomtec SA Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.